Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline

Alice Chen; Kenneth P. Smith; Betsy A. Whitfield; Paola C. Zucchi; Todd M. Lasco; Tiffany E. Bias; James E. Kirby; Elizabeth B. Hirsch

doi:10.1016/j.diagmicrobio.2017.05.004

Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline

Alice Chen, Kenneth P. Smith, Betsy A. Whitfield, Paola C. Zucchi, Todd M. Lasco, Tiffany E. Bias, James E. Kirby, Elizabeth B. Hirsch

Experimental and Clinical Pharmacology

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

We examined the in vitro activity of minocycline against 103 Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae isolates and found approximately half had susceptible (26%) or intermediate (26%) MICs. For a subset of 35 isolates, susceptibility was highest to tigecycline (71% FDA vs. 20% EUCAST) followed by minocycline (14%) and then doxycycline (6%).

Original language	English (US)
Pages (from-to)	365-367
Number of pages	3
Journal	Diagnostic Microbiology and Infectious Disease
Volume	88
Issue number	4
DOIs	https://doi.org/10.1016/j.diagmicrobio.2017.05.004
State	Published - Aug 2017

Keywords

Extended-spectrum beta-lactamase
KPC
Multidrug resistance
Resistant
Tetracycline

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.diagmicrobio.2017.05.004

OpenUrl availability

Full text

Cite this

Chen, A., Smith, K. P., Whitfield, B. A., Zucchi, P. C., Lasco, T. M., Bias, T. E., Kirby, J. E., & Hirsch, E. B. (2017). Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline. Diagnostic Microbiology and Infectious Disease, 88(4), 365-367. https://doi.org/10.1016/j.diagmicrobio.2017.05.004

Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline. / Chen, Alice; Smith, Kenneth P.; Whitfield, Betsy A. et al.
In: Diagnostic Microbiology and Infectious Disease, Vol. 88, No. 4, 08.2017, p. 365-367.

Research output: Contribution to journal › Article › peer-review

Chen, A, Smith, KP, Whitfield, BA, Zucchi, PC, Lasco, TM, Bias, TE, Kirby, JE & Hirsch, EB 2017, 'Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline', Diagnostic Microbiology and Infectious Disease, vol. 88, no. 4, pp. 365-367. https://doi.org/10.1016/j.diagmicrobio.2017.05.004

@article{36f2803bc5e44f75855df42c9be83c51,

title = "Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline",

abstract = "We examined the in vitro activity of minocycline against 103 Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae isolates and found approximately half had susceptible (26%) or intermediate (26%) MICs. For a subset of 35 isolates, susceptibility was highest to tigecycline (71% FDA vs. 20% EUCAST) followed by minocycline (14%) and then doxycycline (6%).",

keywords = "Extended-spectrum beta-lactamase, KPC, Multidrug resistance, Resistant, Tetracycline",

author = "Alice Chen and Smith, {Kenneth P.} and Whitfield, {Betsy A.} and Zucchi, {Paola C.} and Lasco, {Todd M.} and Bias, {Tiffany E.} and Kirby, {James E.} and Hirsch, {Elizabeth B.}",

year = "2017",

month = aug,

doi = "10.1016/j.diagmicrobio.2017.05.004",

language = "English (US)",

volume = "88",

pages = "365--367",

journal = "Diagnostic Microbiology and Infectious Disease",

issn = "0732-8893",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline

AU - Chen, Alice

AU - Smith, Kenneth P.

AU - Whitfield, Betsy A.

AU - Zucchi, Paola C.

AU - Lasco, Todd M.

AU - Bias, Tiffany E.

AU - Kirby, James E.

AU - Hirsch, Elizabeth B.

PY - 2017/8

Y1 - 2017/8

N2 - We examined the in vitro activity of minocycline against 103 Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae isolates and found approximately half had susceptible (26%) or intermediate (26%) MICs. For a subset of 35 isolates, susceptibility was highest to tigecycline (71% FDA vs. 20% EUCAST) followed by minocycline (14%) and then doxycycline (6%).

AB - We examined the in vitro activity of minocycline against 103 Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae isolates and found approximately half had susceptible (26%) or intermediate (26%) MICs. For a subset of 35 isolates, susceptibility was highest to tigecycline (71% FDA vs. 20% EUCAST) followed by minocycline (14%) and then doxycycline (6%).

KW - Extended-spectrum beta-lactamase

KW - KPC

KW - Multidrug resistance

KW - Resistant

KW - Tetracycline

UR - http://www.scopus.com/inward/record.url?scp=85019900749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019900749&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2017.05.004

DO - 10.1016/j.diagmicrobio.2017.05.004

M3 - Article

C2 - 28535946

AN - SCOPUS:85019900749

SN - 0732-8893

VL - 88

SP - 365

EP - 367

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

IS - 4

ER -

Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline

Abstract

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this